December 20th 2024
People with hypertension who adhered to the mobile app demonstrated well-controlled blood pressure over a 12-week observational period.
September 27th 2024
Michael A. Weber, MD, on aprocitentan approval: A new approach to managing hypertension
March 21st 2024Michael A. Weber, MD, an investigator in the PRECISION study, discusses the newly FDA approved drug aprocitentan (Tryvio), and its promise for helping patients with treatment-resistant hypertension.